Otros idiomas Sichuan Kelun Pharmaceutical Co., Ltd.

Acciones

002422

CNE100000PW7

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
33,95 ^CNY	+3,41 %		+13,43 %	+16,87 %

25/04	Sichuan Kelun Pharmaceutical Co. Ltd. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
10/04	Sichuan Kelun Pharmaceutical Co. Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	25/04
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	10/04
US FDA to Accelerate Review of Kelun Pharma Unit's Lung Cancer Drug	12/03
Kelun-Biotech Controlling Shareholder Ups Stake; Shares Rise 4%	23/01
Kelun Pharmaceutical's Olaparib Tablets Get Nod from Chinese Drug Regulator	22/01
Kelun Pharma Gets Registration Approval in China for Immune Thrombocytopenia Drug	17/01
Kelun Pharma Sees Up to 50% Jump in 2023 Profit	16/01
Kelun Pharma's Unit Gets US FDA's Orphan Drug Designation to A400	28/11
Kelun Pharmaceutical's Unit Gains Registration Certificate for Ceftazidime Avibactam Sodium/Sodium Chloride Injection	01/11
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Kelun Pharma Ends Cancer Drug Contract, Revises Partnership With Merck	24/10/23
Global markets live: Foxconn, Roche, Eli Lilly, Chevron, Apple...	23/10/23
The good, the bad and the ugly	23/10/23
Merck discontinues some cancer drug development with China's Sichuan Kelun	23/10/23
Kelun Pharma Unit Obtains Registration Approval in China for Bacterial Infection Drug	18/10/23
Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Sichuan Kelun Pharma to Start License Application Process For New Cancer Drug	15/08/23
Kelun Pharma's Unit Gets Gadobutrol injection Certified	13/07/23
Kelun Pharma Expects Up to 66% Jump in H1 Profit	05/07/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Sichuan Kelun Pharmaceutical Co., Ltd.

Acciones

002422

CNE100000PW7

Otros idiomas

Filtros